来自MSN14 天
15 Inhalers for COPD
It is used for the management of chronic COPD and it can be used as a rescue inhaler as well. It is available as a 45 mcg aerosol or a nebulizer (0.31 mg/3 mL, 0.63 mg/3 mL, 1.25 mg/3 mL, or 1.25 ...
pulmonologyadvisor3 天
Switching Between Inhalers, Both pMDI and DPI, Common in Asthma, COPD
Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers (pMDIs) to dry powder inhalers (DPIs) and vice versa.
pharmaphorum10 天
Asthma and COPD patient adherence: the right inhaler
Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...
MedPage Today1 个月
COPD, Asthma Inhalers Produce Staggering Amounts of Greenhouse Gas Emissions
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Inhalers prescribed to Centers for Medicare & Medicaid Services (CMS) beneficiaries for asthma and chronic obstructive ...
Medscape26 天
Majority of Hospitalized Patients With COPD Misuse Inhalers
Approximately two thirds of hospitalized adults with chronic obstructive pulmonary disease (COPD) received suboptimal treatment with inhalers, mainly resulting from errors, based on data from 96 ...
Renal & Urology News4 天
Extrafine Single Inhaler Triple Therapy Is Effective in Patients With COPD
Extrafine single inhaler triple therapy is effective among patients with COPD who were previously treated with multiple-inhaler triple therapy.
The Victoria Advocate1 个月
Improper Inhaler Use by People With COPD Is Common, Worsening Disease
Over 30 million Americans have COPD, and most use some form of inhaled medicine New research suggests that the majority of COPD patients might be using their inhalers improperly, impeding their ...
Medindia9 个月
COPD Patients Using Beta-agonist Inhalers Are at Risk
A new analysis that compares two common inhalers for patients suffering from chronic obstructive pulmonary disease (COPD) finds that one reduces respiratory-related hospitalizations and ...
Medscape13 天
COPD News
Reuters Health Information, September 06, 2024 Analysis-Ozempic on Wall Street's List for 2027 Medicare ... 2024 US FDA Approves Verona Pharma's Inhaled COPD Therapy The U.S. Food and Drug ...
Everyday Health10 天
FDA Approves Dupixent for Some Patients Struggling With COPD Symptoms
The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.
The Grand Junction Daily Sentinel1 个月
Improper Inhaler Use by People With COPD Is Common, Worsening Disease
FRIDAY, Aug. 23, 2024 (HealthDay News) -- Millions of people rely on medicines delivered by an inhaler to help manage chronic obstructive pulmonary disorder (COPD). But a new European study finds ...